The results indicated that NCOA7 was overexpressed in breast tumors and that its expression was reversely associated with the survival of patients with breast cancer, suggesting that it may be a biomarker for poor prognosis of breast cancer. This evidence concerns the gene NCOA7 and breast cancer.